United States · Funded startup

Who invested in Inherent Biosciences

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$1.9Mraised across 1 round since 2023, from 1 source

Latest round
Grant, $1.9MAug 2023
Investors
3
See who backed them

The rounds

  1. Aug 2023
    Grant$1.9M

    Source recordedSEC filing: $1.5M sold, first sale Aug 2022

Everyone who backed them

KickstartVC firm1round
PortfoliaVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Inherent Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Park City AngelsAngel networkPer its own site
HealthTech InvestorsVC firmPer its own site

Quick answers about Inherent Biosciences

Who invested in Inherent Biosciences?

Inherent Biosciences's investors include National Science Foundation, Kickstart and Portfolia.

How much has Inherent Biosciences raised?

Inherent Biosciences has raised $1.9M across 1 round since 2023.

When did Inherent Biosciences last raise?

Inherent Biosciences's most recent round was a Grant of $1.9M in Aug 2023.

What was Inherent Biosciences's biggest round?

Its most recent round, $1.9M in Aug 2023, is also its largest on record.

Who backed Inherent Biosciences first?

Inherent Biosciences's first round on record, in Aug 2023, was backed by National Science Foundation, Kickstart and Portfolia.

What stage is Inherent Biosciences at?

Inherent Biosciences's latest named round is a Grant, in Aug 2023.

Where is Inherent Biosciences based?

Inherent Biosciences is based in the United States.

Companies like Inherent Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.